透過您的圖書館登入
IP:52.15.59.163
  • 期刊

醫藥發明之專利個案探討:以我國長青樹藥品專利為例

A Study on Pharmaceutical Patents: Some Observations from Evergreening Patent of Pharmaceutical Sector in Taiwan

摘要


專利法賦予發明人於一定期間享有排他性權利,其乃鼓勵醫藥研發之重要制度。相較於其他產業,醫藥領域之研發成本高及風險大,法律制度上應使醫藥業者之研究成果獲得足夠保護及享有研發誘因。相對的,醫藥發明若受到過廣的智慧財產保護,不僅不利於學名藥廠參與競爭,亦對公共衛生政策之落實有不利影響。近年來,醫藥專利權行使而阻礙學名藥上市及醫藥領域之「長青樹專利」問題,在國際間引起關注與討論,醫藥業者不當利用專利策略之現象,亦已在我國浮現。本文以我國准予之活性代謝物、組合藥品及藥品併用醫藥組成物等專利個案為例,探討醫藥發明之可專利性標準及其權利行使問題。

並列摘要


Patent law plays a decisive role in stimulating the development of new medical products by offering an exclusive right as incentive for investing in expensive and long-term research. Without patents, existing medical products would not have been invented, and innovative and better medical products needed to overcome the diseases would not be developed. However, the tendency of patent protection expansion and the inadequate enforcement of patent rights in the pharmaceutical fields seem to impede the access of medicine and adversely affect the implementation of public health. Also the issues over patent-related barriers to market entry for generic medicines and ”evergreening patents” in pharmaceutical industry have aroused strong opinions from the public in recent years. It is noteworthy that the inappropriate development and implementation of pharmaceutical patent strategy occur in Taiwan too. This article reviews the patentability of pharmaceutical inventions and enforcement of patent rights from Taiwan Jurisprudence, using the active metabolite, combination preparation and compositions of combination therapies as examples.

參考文獻


王立達()。
王立達(2004)。從TRIPS 協定與公眾健康爭議論專利強制授權之功能與侷限。科技法學評論。1(1),215-246。
王世晞(2003)。製藥產業之演進、現況與趨勢。National Taiwan University。
王澤鑑(2006)。侵權行為法(二):特殊侵權行為。台北=Taipei:自刊=Author。
李素華、謝銘洋()。

被引用紀錄


佟思敏(2016)。我國扶植生物技術相關產業政策成果及相關規範之研究-以專利計量學面向觀察為基礎〔碩士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU201601351
林建良(2014)。癌症基因治療發明之保護-以專利適格性為中心〔碩士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2014.01751
林義吉(2016)。藥廠發展策略之研究-以P公司為例〔碩士論文,逢甲大學〕。華藝線上圖書館。https://doi.org/10.6341/fcu.M0322007
王彥婷(2013)。由自由貿易協定藥品智慧財產權條款發展趨勢看台灣藥品法制走向〔碩士論文,國立清華大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0016-2211201316570762
羅國彥(2016)。智慧財產權保護之國際政治經濟分析─以醫藥品專利之寡佔為例〔碩士論文,國立中正大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0033-2110201614044270

延伸閱讀